Literature DB >> 19249561

Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs.

L Lodewijk1, A Mall, C W Spearman, D Kahn.   

Abstract

In liver transplantation the graft has been known to undergo regeneration, which is associated with down-regulation of the cytochrome P450 system. The latter is involved in the metabolism of several immunosuppressive drugs. The aim of this study was to investigate the effect of liver regeneration on the pharmacokinetics (PK) of cyclosporine, rapamycin, and tacrolimus. Rats were subjected to either partial hepatectomy (PH) or sham operation (SH). Cyclosporine, rapamycin, and tacrolimus PK studies were performed at 0, 24, and 96 hours postoperatively. The areas under the curve (AUC), trough levels, and maximum concentrations (Cmax) for cyclosporine and tacrolimus were numerically higher in the animals subjected to PH. The PK studies of rapamycin were not affected by PH. These studies indicated that cyclosporine and tacrolimus metabolism may be inhibited during liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249561     DOI: 10.1016/j.transproceed.2008.10.055

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.

Authors:  Xiaoqing Zhang; Zhaowen Wang; Junwei Fan; Gaolin Liu; Zhihai Peng
Journal:  Eur J Clin Pharmacol       Date:  2011-02-26       Impact factor: 2.953

2.  Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation.

Authors:  Eunhee Ji; Leena Choi; Kyung-Suk Suh; Joo-Youn Cho; Nayoung Han; Jung Mi Oh
Journal:  Transplantation       Date:  2012-10-27       Impact factor: 4.939

3.  Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients.

Authors:  Abdulkareem Albekairy; Abdulmalik Alkatheri; Shiro Fujita; Alan Hemming; Richard Howard; Alan Reed; Janet Karlix
Journal:  Saudi J Gastroenterol       Date:  2013 Mar-Apr       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.